Skip to main content
Top
Published in: Clinical Rheumatology 6/2004

01-12-2004 | Case Report

Pregnancy in Wegener’s granulomatosis: successful treatment with intravenous immunoglobulin

Authors: Francesca Bellisai, Gabriella Morozzi, Roberto Marcolongo, Mauro Galeazzi

Published in: Clinical Rheumatology | Issue 6/2004

Login to get access

Abstract

We present the case of a women diagnosed with Wegener’s disease at the age of 26 years, refractory to corticosteroid and cyclophosphamide therapy. Treatment with intravenous immunoglobulin (IVIg) was started, leading to partial clinical remission of disease. During IVIg treatment she became pregnant. IVIg therapy was continued, the disease went into remission, and after 40 weeks the patient delivered a healthy boy. After 6 months from the delivery, the patient became pregnant again. Now she is at the 22nd week of pregnancy and she is doing very well. This case supports the beneficial effect of IVIg in Wegener’s granulomatosis and illustrates its safety and efficacy during pregnancy.
Literature
1.
go back to reference Cohen Tervaert JW, Van der Woude FJ, Fauci AS, Ambrus JL, Velosa J, Keane WF, et al. (1989) Association between active Wegener’s granulomatosis and anticytoplasmic antibodies. Arch Intern Med 149:2461–2465CrossRefPubMed Cohen Tervaert JW, Van der Woude FJ, Fauci AS, Ambrus JL, Velosa J, Keane WF, et al. (1989) Association between active Wegener’s granulomatosis and anticytoplasmic antibodies. Arch Intern Med 149:2461–2465CrossRefPubMed
2.
go back to reference Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488–498PubMed Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488–498PubMed
3.
go back to reference Jayne DRW, Chapel H, Adu D, Misbah S, O’Donoghue D, Scott D, et al. (2000) Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM 93:433–439CrossRefPubMed Jayne DRW, Chapel H, Adu D, Misbah S, O’Donoghue D, Scott D, et al. (2000) Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM 93:433–439CrossRefPubMed
4.
go back to reference Thomas-Golbanov C, Sridharan S (2001) Novel therapies in vasculitis. Expert Opin Investig Drugs 10:1279–1289PubMed Thomas-Golbanov C, Sridharan S (2001) Novel therapies in vasculitis. Expert Opin Investig Drugs 10:1279–1289PubMed
5.
go back to reference Jennette JC, Falk RJ, Andrassy K, Bacon PA Churg J, Gross WL, et al. (1994) Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 37:187–192PubMed Jennette JC, Falk RJ, Andrassy K, Bacon PA Churg J, Gross WL, et al. (1994) Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 37:187–192PubMed
6.
go back to reference Mouthon L (1999) Treatment of ANCA-positive systemic vasculitis with intravenous immunoglobulins. Rev Med Interne 20 [Suppl 4]:431s–435s Mouthon L (1999) Treatment of ANCA-positive systemic vasculitis with intravenous immunoglobulins. Rev Med Interne 20 [Suppl 4]:431s–435s
7.
go back to reference Levy Y, Sherer Y, George J, Langevitz P, Ahmed A, Bar-Dyan Y, et al. (1999) Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin. Int Arch Allergy Immunol 119:231–238CrossRefPubMed Levy Y, Sherer Y, George J, Langevitz P, Ahmed A, Bar-Dyan Y, et al. (1999) Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin. Int Arch Allergy Immunol 119:231–238CrossRefPubMed
8.
go back to reference Rossi F, Jayne DRW, Lockwood CM, Kazatchkine MD (1991) Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis. Clin Exp Immunol 83:298–303PubMed Rossi F, Jayne DRW, Lockwood CM, Kazatchkine MD (1991) Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis. Clin Exp Immunol 83:298–303PubMed
9.
go back to reference Brooks CJ, King WJ, Radford DJ, Adu D, McGrath M, Savage COS (1996) IL-1 beta production by human polymorphonuclear leucocytes stimulated by anti-neutrophil cytoplasm autoantibodies. Clin Exp Immunol 106:273–279CrossRefPubMed Brooks CJ, King WJ, Radford DJ, Adu D, McGrath M, Savage COS (1996) IL-1 beta production by human polymorphonuclear leucocytes stimulated by anti-neutrophil cytoplasm autoantibodies. Clin Exp Immunol 106:273–279CrossRefPubMed
10.
go back to reference Talbot SF, Main DM, Levinson AI (1984) Wegener’s granulomatosis: first report of a case with onset during pregnancy. Arthritis Rheum 27:109–112PubMed Talbot SF, Main DM, Levinson AI (1984) Wegener’s granulomatosis: first report of a case with onset during pregnancy. Arthritis Rheum 27:109–112PubMed
11.
go back to reference Auzary C, Huong DT, Wechsler B, Vauthier-Brouzes D, Piette JC (2000) Pregnancy in patients with Wegener’s granulomatosis: report of five cases in three women. Ann Rheum Dis 59:800–804CrossRefPubMed Auzary C, Huong DT, Wechsler B, Vauthier-Brouzes D, Piette JC (2000) Pregnancy in patients with Wegener’s granulomatosis: report of five cases in three women. Ann Rheum Dis 59:800–804CrossRefPubMed
12.
go back to reference Kumar A, Mohan A, Gupta R, Singal VK, Garg OP (1998) Relapse of Wegener’s granulomatosis in the first trimester of pregnancy: a case report. Br J Rheumatol 37:331–333CrossRefPubMed Kumar A, Mohan A, Gupta R, Singal VK, Garg OP (1998) Relapse of Wegener’s granulomatosis in the first trimester of pregnancy: a case report. Br J Rheumatol 37:331–333CrossRefPubMed
13.
go back to reference Lima F, Buchanan N, Froes L, Kerslake S, Khamashta MA, Hughes GRV (1995) Pregnancy in granulomatous vasculitis. Ann Rheum Dis 54:604–606PubMed Lima F, Buchanan N, Froes L, Kerslake S, Khamashta MA, Hughes GRV (1995) Pregnancy in granulomatous vasculitis. Ann Rheum Dis 54:604–606PubMed
14.
go back to reference Cowchock S (1996) Prevention of fetal death in the anti-phospholipid antibody syndrome. Lupus 5:467–472PubMed Cowchock S (1996) Prevention of fetal death in the anti-phospholipid antibody syndrome. Lupus 5:467–472PubMed
15.
go back to reference Rutberg SA, Ward DE, Roth BJ (2002) Churg-Strauss syndrome and pregnancy. Successful treatment with intravenous immunoglobulin. J Clin Rheumatol 8:151–156CrossRef Rutberg SA, Ward DE, Roth BJ (2002) Churg-Strauss syndrome and pregnancy. Successful treatment with intravenous immunoglobulin. J Clin Rheumatol 8:151–156CrossRef
Metadata
Title
Pregnancy in Wegener’s granulomatosis: successful treatment with intravenous immunoglobulin
Authors
Francesca Bellisai
Gabriella Morozzi
Roberto Marcolongo
Mauro Galeazzi
Publication date
01-12-2004
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 6/2004
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-004-0932-5

Other articles of this Issue 6/2004

Clinical Rheumatology 6/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.